[HTML][HTML] lncRNA NEAT1: Key player in neurodegenerative diseases

K Li, Z Wang - Ageing Research Reviews, 2023 - Elsevier
Neurodegenerative diseases are the most common causes of disability worldwide. Given
their high prevalence, devastating symptoms, and lack of definitive diagnostic tests, there is …

Amyotrophic lateral sclerosis

O Hardiman, A Al-Chalabi, A Chio, EM Corr… - Nature reviews Disease …, 2017 - nature.com
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized
by the degeneration of both upper and lower motor neurons, which leads to muscle …

Supportive and symptomatic management of amyotrophic lateral sclerosis

EV Hobson, CJ McDermott - Nature Reviews Neurology, 2016 - nature.com
The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to
minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive …

The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral …

Y Nishimoto, S Nakagawa, T Hirose, HJ Okano… - Molecular brain, 2013 - Springer
Background A long non-coding RNA (lncRNA), nuclear-enriched abundant transcript 1_2
(NEAT1_2), constitutes nuclear bodies known as “paraspeckles”. Mutations of RNA binding …

End-of-life management in patients with amyotrophic lateral sclerosis

S Connolly, M Galvin, O Hardiman - The Lancet Neurology, 2015 - thelancet.com
Most health-care professionals are trained to promote and maintain life and often have
difficulty when faced with the often rapid decline and death of people with terminal illnesses …

The changing picture of amyotrophic lateral sclerosis: lessons from European registers

O Hardiman, A Al-Chalabi, C Brayne… - Journal of Neurology …, 2017 - jnnp.bmj.com
Prospective population based-registers of amyotrophic lateral sclerosis (ALS) have operated
in Europe for over two decades, and have provided important insights into our …

Respiratory management of patients with neuromuscular weakness: an American college of chest physicians clinical practice guideline and expert panel report

A Khan, L Frazer-Green, R Amin, L Wolfe, G Faulkner… - Chest, 2023 - Elsevier
Background Respiratory failure is a significant concern in neuromuscular diseases (NMDs).
This CHEST guideline examines the literature on the respiratory management of patients …

Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China

L Chen, B Zhang, R Chen, L Tang, R Liu… - Journal of Neurology …, 2015 - jnnp.bmj.com
Objectives To describe the natural history and clinical features of sporadic amyotrophic
lateral sclerosis (ALS) in Chinese patients, and to report data on the prognostic factors for …

Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort

DJ Berlowitz, ME Howard, JF Fiore… - Journal of Neurology …, 2016 - jnnp.bmj.com
Background Respiratory failure is associated with significant morbidity and is the
predominant cause of death in motor neurone disease/amyotrophic lateral sclerosis …

Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives

M Boentert - Nature and science of sleep, 2019 - Taylor & Francis
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease inevitably leading
to generalized muscle weakness and premature death. Sleep disturbances are extremely …